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Abstract
Background: Belarus has a focused HIV epidemic concentrated among injecting drug users, female sex workers
and men who have sex with men. However, until 2008, Belarus had no way of evaluating HIV spending priorities.
In 2008, Belarus committed to undertaking a comprehensive National AIDS Spending Assessment (NASA) in order
to analyze HIV spending priorities. NASA was used to ‘follow the money’ from the funding sources to agents and
providers, and eventually to beneficiary populations.
Findings: Belarus spent the majority of its funding on prevention, diagnosis and treatment of sexually transmitted
infections and on securing the blood supply. International donors and NGOs working within Belarus spent the
majority of their funding on preventative activities for high risk groups while Global Fund to Fight AIDS,
Tuberculosis, and Malaria (GFATM) solely funded antiretroviral treatment.
Conclusions: The data and experience obtained through conducting NASA will help build capacity for future
resource tracking activities for HIV and other health priorities. This experience established the foundation for
enhanced and future consistent quality-reporting of National Health Accounts. Monitoring the flow of resources for
Belarus’ HIV response provides valuable strategic information that can improve operations and planning as well as
mobilize greater resources. NASA offers Belarusian policy makers an overview of HIV activities that merit their
priority attention. In addition, the findings from Belarus are particularly relevant for the rest of the Commonwealth
of Independent States due to their similar epidemiological profiles and centrally planned systems. The Belarusian
government faces future challenges, especially in increasing public investments in HIV prevention for female sex
workers and their clients, men who have sex with men, and among intravenous drug users.
Background
Belarus was minimally impacted by HIV until 1996-1997,
when an HIV outbreak in Svetlogorsk increased the
number of infected individuals by more than tenfold [1],
since then, a total of 10,690 cases of HIV have been regis-
tered with an estimated 17,000 cases as of 2009 [2]. The
country still has a relatively low prevalence rate (0.2-
0.3%); the epidemic is concentrated among injecting drug
users (IDUs), female sex workers (FSW) and men who
have sex with men (MSM) with 13.7, 2.7 and 6.4 percent
prevalence rates respectively [2,3]. Estimates of the num-
ber of IDUs in the country range from 62,000 to 77,000
[4,5]. The majority of HIV positive people are between
the ages of 15-29 [5].
Belarus, an upper-middle income country [6] with a
population of 9.6 million, is located in the center of
Europe and is surrounded by Russia, Ukraine, Poland,
Lithuania and Latvia [5]. The country has no access to the
sea, but it is located in an important location, facilitating
trade and travel between Europe and the Commonwealth
of Independent States (CIS) [5]. In 2008, GDP was $US
60.343 billion with a ten percent growth rate from the pre-
vious year [5]. 6.5 percent of GDP was spent on public
health including 3.6 percent of government spending and
2.9 percent of non-governmental (NGO) spending.
The literature has suggested that countries will have
to make hard decisions about where to allocate HIV
funding due to impending financing shortages [7,8]. For
this reason, Belarus committed to undertake a form of
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spending patterns for HIV treatment and HIV related
activities. With this information, they hoped to be
able to make more informed decisions about funding
allocation as well as anticipating future threats to sus-
tainability. In 2008, Belarus implemented their first
comprehensive National AIDS Spending Assessment
(NASA) of public, international and private HIV-related
expenditures. Using the most recently available data,
this paper describes HIV spending patterns in Belarus
and their implications for future policy decisions.
Methods
A comprehensive tracking and analysis of HIV expendi-
tures in 2008 was conducted by training and overseeing
resource tracking teams covering each one of the six
voblasts and Minsk; Minsk capital, Brest, Gomel, Grodno,
Minsk Region, Mogilev and Vitebsk. A review of key pol-
icy documents, program documentation and budgetary
expenditure reports was performed using standard meth-
odology, formats and definitions [5]. All resource track-
ing teams were trained on using the standard NASA
framework to ensure accuracy. Adoption of the official
AIDS spending report by the Ministry of Health made it
possible to include all of the healthcare organizations in
the country [5]. All expenditures, by programmatic activ-
i t ya n dH I Vs e r v i c e s ,w e r ec r o s s - t a b u l a t e db ys o u r c eo f
financing and stratified by income level using the NASA
framework.
NASA is a tool developed by UNAIDS to measure the
entirety of resources included in a country’s national HIV
response; it was developed using the national health
accounts framework and principles [9,10]. NASA applies
standard accounting methods to reconstruct all transac-
tions in a given country, ‘following the money’ from the
funding sources to agents and providers, and eventually
to beneficiary populations. The NASA methodology was
approved by the UNAIDS Global Consortium of
Resource Tracking in 2006 and has been used to report
progress on the 2001 Declaration of Commitment from
the UN General Assembly Special Session on HIV/AIDS
(UNGASS). It additionally supports countries in planning
and monitoring their HIV activities.
NASA analyses include levels and patterns of domestic
HIV spending from public and international sources
down to the recipient population. HIV spending is
structured into eight categories of spending: (1) preven-
tion; (2) treatment and care; (3) orphans and vulnerable
children; (4) program management and administration;
(5) human resources; (6) social protection; (7) enabling
environment; and (8) research. NASA spending cate-
gories are also divided into a functional classification
that includes health and non-health HIV services [11].
The NASA process and collection of spending flows
requires significant collaboration among government
agencies and international organizations. In Belarus,
these organizations included the following: the Ministry
of Health of Belarus, the National Center for Hygiene,
Epidemiology and Public Health, projects of the United
Nations Development Program, The Global Fund to
fight AIDS, Tuberculosis and Malaria (GFATM),
UNAIDS and various NGOs. The UNAIDS country
coordinator worked closely with the local NASA team
to organize the NASA process in country.
Results
In 2008, Belarus spent more than US$ 19 million on
HIV/AIDS with public service providers accounting for
82 percent (US$ 15.6 million) of the total spending
(Table 1). International service providers (NGOs and
multi-lateral organizations) represented 10 percent (US$
1.9 million) of the total with private out-of-pocket
expenditures on condoms comprising the remaining 8
percent (US$ 1.5 million). The sources of financing were
comprised of 68 percent public funds (US$ 12.96 mil-
lion), 22 percent international funds (US$ 4.28 million)
and 10 percent private funds (US$ 1.86 million). Preven-
tion spending was over 70 percent of the total spending
for HIV in 2008; and, of the US$ 13.5 million spent on
prevention, almost US$ 10.3 million originated from
government expenditures. Intervention areas receiving
the next highest amount of contributions included care,
and treatment as well as program management, which
accounted for 12.9 and 8.6 percent of total expenditures
respectively. Due to the high amount of expenditures on
prevention, it is constructive to look at a breakdown of
prevention spending to assess both country and interna-
tional priorities.
While prevention is clearly a priority, it is necessary to
evaluate if current spending is targeting the most at-risk
populations. Figure 1 provides a glimpse of some of the
highest spending categories within prevention/care and
treatment broken down by government funding and
international funding. This figure elucidates the key
priorities of the Belarusian government which include
prevention, diagnosis and treatment of sexually trans-
mitted infections [12] and investments in blood safety.
I nc o n t r a s t ,p r o g r a m sf o rF S W s ,M S M ,a n dI D U sa r e
supported primarily by international funding. These
represent a low percentage of the overall spending on
prevention.
The anti-retroviral drug acquisition [13] program is
completely supported by GFATM. Prophylaxis and
treatment of opportunistic infections, specific HIV-
related laboratory monitoring and communication for
social and behavioral change were also financed from
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Private Percent
Private
Public Percent
Public
International (NGO/
Multi-Lateral)
Percent
International
Total
Sources of Finance 4,275,076 10% 12,956,893 68% 12,956,893 22% 19,095,705
Intervention Areas by Service
Provider
Prevention 1,514,216 11% 10,973,620 81% 1,062,269 8% 13,550,105
Care and Treatment - 2,298,965 93% 164,178 7% 2,463,143
Orphans and Vulnerable Children
(OVC)
- 93,995 100% - 0% 93,995
Program Management - 1,035,586 63% 608,810 37% 1,644,396
Human Capital - 501,418 89% 64,927 11% 566,345
Social Protection and Social services
(excluding OVC)
- 326,173 100% - 0% 326,173
Enabling environment and
community development
- 5,898 15% 33,629 85% 39,527
HIV-related research (excluding
operations research)
- 411,553 100% 468 0% 412,021
Total 1,514,216 8% 15,647,208 82% 1,934,281 10% 19,095,705
Figure 1 Key Spending Areas in Prevention and Treatment and Care.
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[5].
Though out-of-pocket private spending covered pay-
ment for condoms, total out-of-pocket expenditures on
HIV and AIDS may be underestimated. Household
spending for any other forms of prevention or treatment
was not captured in this study and thus also may be
underestimated.
Discussion
While HIV spending in Eastern Europe has significantly
increased in recent years, this is the first comprehensive
report analyzing data on HIV spending from one of the
Commonwealth of Independent States (CIS) [14]. The
resource tracking system in place documented that
Belarus spent more than US$ 19 million on the AIDS
response in 2008. While treatment and care represents
about 13 percent of the total, more than 70 percent of
expenditures were channelled to preventive activities.
Once adjusted for the size of the Belarusian population,
the per capita spending was US$ 1.98, which is compar-
able to the average per capita spending on HIV reported
from other low and middle income countries [15].
Despite the financial constraints experienced by
Belarus, the government has been substantially increasing
investments in the social sector, particularly in the area of
prevention. Analysis of health expenditures showed per
capita spending increasing from US$ 66 in 2000, US$
147 in 2004 up to US$ 406 in 2008 - a six-fold increase
in eight years [16]. Belarus also was the first country in
the CIS to reverse overall economic decline with sizeable
growth rates averaging 9 percent per annum between
2003 and 2008; during this time period, per capita
income tripled, delivering one of the highest poverty rate
reductions in the region [16]. The current spending pat-
terns from public sources reflect the emphasis of HIV
programmes based on health facilities as 63% of the
resources were directed to two interventions; STI treat-
ment and blood safety.
High rates of STI in Eastern Europe are a major pub-
lic health concern and a potential risk factor for HIV
transmission. Case reports and service utilization for
STIs are indirect proxies of unsafe sex. Relevant figures
for C. trachomatis and N. gonorrhoeae infections have
been reported in the region [17]. The presence of an
untreated ulcerative or non-ulcerative infection increases
the risk of both acquisition and transmission of HIV.
Thus, investments in diagnosis and treatment for STIs
are important to reduce the risk of HIV infection. A
third of the total spending in prevention was allocated
to STIs programmes in Belarus. This funding supported
the creation of a medical specialist’s task force on STI
directing prevention activities among female sex workers
and MSM in the major Belarusian cities (Minsk, Brest,
Vitebsk, Grodno, Gomel, Mogilev and Svetlogorsk) [18].
Work on prevention of HIV and STIs has been inte-
grated into counselling centers complemented by com-
munity outreach workers; condoms, testing and
treatment of STIs, and psychological support are pro-
vided. Services for sex workers and MSM account for
an annual average of 3,000 consultations, 600 STI treat-
ments, almost one million condoms provided and
30,000 printed materials distributed [18].
Screening all donated blood for HIV in accordance
with minimum quality standards remains vital. Progress
has been made toward eliminating blood transfusion as a
significant cause of HIV infection in the region. However,
the number and percentage of donations screened in
Eastern Europe and Central Asia is relatively low,
reported to be 76%, albeit with important regional varia-
tion [19]. In Belarus, as the allocation of resources shows
and consistent with the country report, 100% of donated
blood units are screened for HIV in a quality assured
manner [18]. Blood safety programmes are a priority in
Belarus and a significant amount of resources support
these programs.
Total care and treatment spending was US$ 2.5 million
(13% out of the total) and includes provider initiated test-
ing and counselling, treatment and prophylaxis for
opportunistic infections, antiretroviral therapy, laboratory
monitoring for 1,250 PLWH as well as palliative care
[20]. Almost 50% of these resources were spent on ARV
medicines and an additional 10% in laboratory monitor-
ing. Most of the resources for treatment and care were
funded by international sources (55%) and an interrupted
s u p p l yo fA R V si sp o s s i b l eu n d e rac o m p l e t e l yG F A T M -
funded project.
Providers of care are also important partners in the
response to HIV. In Belarus, the providers are Ministry of
Health facilities, department facilities including hospitals
and clinics, multilateral agencies, NGOs and private facil-
ities. Hospitals and clinics play key roles in providing care
and prevention, but they could also find innovative ways
to create enabling environments and some social services
at limited additional cost. The efforts must not be comple-
tely top-down, but rather allowing local creativity to inno-
vate and work within a fixed budget.
Monitoring the flow of resources for the HIV response
provides valuable information for improving operations
and planning, and mobilizing greater resources. NASA
offers Belarusian policy makers an overview of HIV activ-
ities requiring their attention. It emphasizes issues rele-
vant to the effective use of resources within the health
sector. For example, it has been documented that harm
reduction activities among intravenous drug users can be
cost-effective. A recent study showed cost-effectiveness
of US$ 359 per HIV infection averted in Svetlogorsk,
Belarus [21]. The same study also showed how relatively
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effectiveness. Yet, Belarus is among the few countries of
the CIS who realize the need to prioritize resources
among groups where a sizable funding gap exists. The
mapping of HIV expenditures provides crucial guidance
for the reallocation of resources while supporting evi-
dence-based decision making.
An uncontrolled, concentrated epidemic, if left alone
has the potential to turn into a generalized epidemic.
Increased public investment in HIV prevention for high
risk groups including FSWs and their clients, MSM, and
especially IDUs, is critical to containing the epidemic.
Without any targeted interve n t i o n ,i ti sl i k e l yt h a tH I V
prevalence will continue to increase among these groups
in Belarus [5]. Finally, it is necessary to ensure that
there is active dialogue and consultation with civil
society, including the private sector, on the reform pro-
gram. Both country health priorities for immediate
response as well as longer-term measures must be
discussed.
Conclusion
The data and experience obtained through conducting
NASA for 2008 will help build capacity for future
resource tracking activities for HIV and other health
priorities. This experience established the foundation for
enhanced and future consistent quality-reporting of
National Health Accounts. This newly laid foundation
with improved quality-reporting will enable implementa-
tion and regular improvement of the monitoring of the
national response to HIV and tracking the efficiency of
HIV-related programs and activities. Additionally, it will
serve as a basis for improving national strategic planning
in health.
The CIS was created a successor entity to the Union of
Soviet Socialist Republics (USSR). Many of the current
members are from centrally planned economies and
therefore have health systems that are similar to Belarus.
In Eastern Europe, they key modes of HIV transmission
are injecting drug use and sex work [22]. Due to the simi-
lar epidemiological profiles of the CIS countries they can
benefit from the knowledge gained in Belarus. One of the
key lessons for these countries is the importance of
increased targeted prevention efforts at high risk groups,
especially injecting drug users.
The results from the current AIDS resource tracking
exercise in Belarus have been an extremely useful exercise
which has generated evidence to guide future policy deci-
sions. The government of Belarus is contributing to the
majority of the expenditures for HIV and is the driving
force behind prevention. As the present study demon-
strates, the majority of prevention spending has been
focused on diagnosis and treatment of STIs in the general
population while another significant portion of the funding
is focused on securing a safe blood supply. The govern-
ment faces future challenges, especially in increasing pub-
lic investments in HIV prevention for female sex workers
and their clients, men who have sex with men, and intra-
venous drug users. NASA has helped establish current
resource allocations and highlighted the critical role of
these investments in containing the HIV epidemic in
Belarus.
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